Helius Medical Technologies, Inc. (HSDT) financial statements (2021 and earlier)
Company profile
| Business Address |
642 NEWTOWN YARDLEY ROAD NEWTOWN, PA 18940 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 3/31/2016 | 3/31/2015 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 3 | 5 | 26 | 6 | 3 | 1 | ||
| Cash and cash equivalents | 3 | 5 | 26 | 6 | 3 | 0 | ||
| Short-term investments | 0 | |||||||
| Receivables | 0 | 1 | 0 | 1 | 0 | 0 | ||
| Inventory, net of allowances, customer advances and progress billings | 0 | 1 | 0 | |||||
| Inventory | 0 | 1 | 0 | |||||
| Prepaid expense | 1 | 1 | 0 | 1 | 0 | |||
| Other current assets | 0 | 0 | ||||||
| Other undisclosed current assets | 0 | |||||||
| Total current assets: | 5 | 7 | 27 | 7 | 4 | 1 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 0 | 1 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 0 | 1 | 1 | 0 | ||||
| Long-term investments and receivables | 0 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 0 | |||||||
| Intangible assets, net (including goodwill) | 1 | 2 | ||||||
| Goodwill | 1 | 1 | ||||||
| Intangible assets, net (excluding goodwill) | 1 | 1 | ||||||
| Other noncurrent assets | 0 | 0 | 0 | |||||
| Total noncurrent assets: | 2 | 3 | 1 | 0 | ||||
| TOTAL ASSETS: | 7 | 10 | 28 | 7 | 4 | 1 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 2 | 3 | 4 | 5 | 2 | 1 | ||
| Accounts payable | 1 | 2 | 2 | 3 | ||||
| Accrued liabilities | 1 | 2 | 2 | 1 | ||||
| Other undisclosed accounts payable and accrued liabilities | 2 | 1 | ||||||
| Deferred revenue | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 0 | |||||||
| Derivative instruments and hedges, liabilities | 0 | 14 | 10 | |||||
| Other undisclosed current liabilities | 0 | 0 | ||||||
| Total current liabilities: | 2 | 4 | 18 | 14 | 2 | 1 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 0 | 0 | ||||||
| Operating lease, liability | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 0 | 0 | 2 | 2 | ||||
| Deferred revenue | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Derivative instruments and hedges, liabilities | 2 | 2 | ||||||
| Total noncurrent liabilities: | 0 | 1 | 2 | 2 | ||||
| Total liabilities: | 3 | 5 | 18 | 14 | 4 | 3 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | 4 | 6 | 10 | (7) | (0) | (2) | ||
| Common stock | 0 | 0 | 0 | 52 | 24 | 16 | ||
| Common stock, value, subscriptions | 0 | |||||||
| Additional paid in capital | 124 | 111 | 105 | 7 | 3 | 2 | ||
| Accumulated other comprehensive income (loss) | (1) | (1) | (1) | 0 | (1) | (1) | ||
| Accumulated deficit | (119) | (105) | (95) | (66) | (26) | (19) | ||
| Total stockholders' equity: | 4 | 6 | 10 | (7) | (0) | (2) | ||
| TOTAL LIABILITIES AND EQUITY: | 7 | 10 | 28 | 7 | 4 | 1 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 1 | 1 | 0 | ||||
| Cost of revenue (Cost of Goods and Services Sold) | (0) | (1) | |||||
| Other undisclosed gross profit | 1 | ||||||
| Gross profit: | 0 | 1 | 0 | ||||
| Operating expenses | (15) | (25) | (27) | (23) | (9) | (7) | |
| Other undisclosed operating loss | (3) | ||||||
| Operating loss: | (14) | (24) | (27) | (23) | (9) | (10) | |
| Nonoperating income (expense) | 0 | 14 | (2) | (5) | 2 | (0) | |
| Foreign currency transaction gain (loss), before tax | 1 | (2) | (0) | 1 | |||
| Other nonoperating income | 0 | 0 | |||||
| Interest and debt expense | 0 | (0) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (14) | (10) | (29) | (28) | (7) | (10) | |
| Other undisclosed income from continuing operations before income taxes | 28 | 20 | 57 | 56 | |||
| Income (loss) before gain (loss) on sale of properties: | 14 | 10 | 29 | 28 | (7) | (10) | |
| Other undisclosed net loss | (28) | ||||||
| Net income (loss): | (14) | 10 | 29 | 28 | (7) | (10) | |
| Other undisclosed net income (loss) attributable to parent | (20) | (57) | (56) | (0) | 0 | ||
| Net loss available to common stockholders, diluted: | (14) | (10) | (29) | (28) | (7) | (10) | |
Comprehensive Income ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (14) | 10 | 29 | 28 | (7) | (10) | |
| Comprehensive income (loss): | (14) | 10 | 29 | 28 | (7) | (10) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (0) | (20) | (58) | (54) | (0) | (1) | |
| Comprehensive loss, net of tax, attributable to parent: | (14) | (10) | (29) | (26) | (7) | (11) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.